Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:840-846

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walsh, B. A.
Right arrow Articles by Rutledge, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walsh, B. A.
Right arrow Articles by Rutledge, J. C.
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Oxidant stress
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:840-846.)
© 1999 American Heart Association, Inc.


Original Contributions

17ß-Estradiol Reduces Glycoxidative Damage in the Artery Wall

Barbara A. Walsh; Bonnie L. Busch; Adam E. Mullick; Karen M. Reiser; John C. Rutledge

From the Department of Medicine, Division of Cardiovascular Medicine (B.A.W., A.E.M., J.C.R.); the Department of Biological Sciences, Division of Neurobiology, Physiology, and Behavior (B.L.B.); and the Department of Medicine, Division of Pulmonary/Critical Care (K.M.R.), University of California, Davis.

Correspondence to John C. Rutledge, MD, Division of Cardiovascular Medicine, One Shields Ave, University of California, Davis, CA 95616-8636. E-mail jcrutledge{at}ucdavis.edu

Abstract—Glycoxidative damage in the vasculature has been linked to atherosclerotic cardiovascular disease. Estrogens protect against the development and progression of atherosclerosis. Because estrogens are potent antioxidants that also effect glucose metabolism, part of their protection against atherosclerosis could be through attenuation of glycoxidative damage in the vascular wall. In this study, we tested the hypothesis that chronic estradiol administration is associated with decreased levels of glycoxidative damage in arterial walls. We harvested and examined iliac arteries from ovariectomized, 8-month-old rats that had been implanted for 6 months with 1 of the following subcutaneous hormone pellets: low estradiol (2.5 mg estradiol), high estradiol (25 mg estradiol), P4 (200 mg progesterone), low estradiol and P4, placebo (no hormone), or control (no implant). Using pentosidine as a biomarker of glycoxidative damage, we found that all vessels from rats receiving estradiol (low estradiol, high estradiol, and low estradiol+P4) exhibited a 50% reduction in glycoxidative damage compared with P4, placebo, and control vessels (P<0.05). Consistent with this finding, we observed that estradiol-treated rats had a 30% decrease in tissue levels of hydroperoxides, a marker of oxidative stress. Finally, estradiol-treated rats had a small, but significant, decrease in plasma glucose levels (P<0.01). In summary, we report the novel finding that chronic estrogen administration is associated with significant decreases in glycoxidative damage and oxidative stress in the arterial wall. It seems likely that these actions may constitute a mechanism by which estrogen attenuates the progression of atherosclerosis.


Key Words: estrogen • glycoxidative damage • oxidant stress • glycemic stress • atherosclerosis




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Benton, A. Powers, L. Eiselein, R. Fitch, D. Wilson, A. C. Villablanca, and J. C. Rutledge
Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R723 - R730.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. E. Mullick, J. M. McDonald, G. Melkonian, P. Talbot, K. E. Pinkerton, and J. C. Rutledge
Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H591 - H597.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. D. Symons, A. E. Mullick, J. L. Ensunsa, A. A. Ma, and J. C. Rutledge
Hyperhomocysteinemia Evoked by Folate Depletion: Effects on Coronary and Carotid Arterial Function
Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): 772 - 780.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. E. Mullick, B. A. Walsh, K. M. Reiser, and J. C. Rutledge
Chronic estradiol treatment attenuates stiffening, glycoxidation, and permeability in rat carotid arteries
Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2204 - H2210.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. K. Dubey and E. K. Jackson
Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms
Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388.
[Abstract] [Full Text] [PDF]